Search Results - "Furmaga, Wieslaw B"

Nano-bio-chips for high performance multiplexed protein detection: Determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels by Jokerst, Jesse V., Raamanathan, Archana, Christodoulides, Nicolaos, Floriano, Pierre N., Pollard, Amanda A., Simmons, Glennon W., Wong, Jorge, Gage, Carole, Furmaga, Wieslaw B., Redding, Spencer W., McDevitt, John T.

“…The integration of semiconductor nanoparticle quantum dots (QDs) into a modular, microfluidic biosensor for the multiplexed quantitation of three important…”
Get full text

Programmable bio-nano-chip systems for serum CA125 quantification: toward ovarian cancer diagnostics at the point-of-care by Raamanathan, Archana, Simmons, Glennon W, Christodoulides, Nicolaos, Floriano, Pierre N, Furmaga, Wieslaw B, Redding, Spencer W, Lu, Karen H, Bast, Jr, Robert C, McDevitt, John T

“…Point-of-care (POC) implementation of early detection and screening methodologies for ovarian cancer may enable improved survival rates through early…”
Get full text

Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care by Christodoulides, Nicolaos, Pierre, Floriano N, Sanchez, Ximena, Li, Luanyi, Hocquard, Kyle, Patton, Aaron, Muldoon, Rachna, Miller, Craig S, Ebersole, Jeffrey L, Redding, Spencer, Yeh, Chih-Ko, Furmaga, Wieslaw B, Wampler, David A, Bozkurt, Biykem, Ballantyne, Christie M, McDevitt, John T

“…Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is…”
Get full text

Alu profiling of primary and metastatic nonsmall cell lung cancer by Furmaga, Wieslaw B, Ryan, Julie L, Coleman, William B, Cole, Solon R, Tsongalis, Gregory J

“…The metastatic potential of nonsmall cell carcinoma of lung (NSCLC), is currently recognized post factum, when lymph nodes or distant organs are already…”
Get full text

Programmable Bio-Nano-Chip Systems for Serum CA125 Quantification: Towards Ovarian Cancer Diagnostics at the Point-of-Care by Raamanathan, Archana, Simmons, Glennon W., Christodoulides, Nicolaos, Floriano, Pierre N., Furmaga, Wieslaw B., Redding, Spencer W., Lu, Karen H., Bast, Robert C., McDevitt, John T.

“…Point-of-care (POC) implementation of early detection and screening methodologies for ovarian cancer may enable improved survival rates through early…”
Get full text

Programmable Bio-Nano-Chip Technology for the Diagnosis of Cardiovascular Disease at the Point-of-Care by Christodoulides, Nicolaos, Pierre, Floriano N., Sanchez, Ximena, Li, Luanyi, Hocquard, Kyle, Patton, Aaron, Muldoon, Rachna, Miller, Craig S., Ebersole, Jeffrey L., Redding, Spencer, Yeh, Chih-Ko, Furmaga, Wieslaw B., Wampler, David A., Bozkurt, Biykem, Ballantyne, Christie M., McDevitt, John T.

“…Cardiovascular disease remains the leading cause of death in the world and continues to serve as the major contributor to healthcare costs. Likewise, there is…”
Get full text